Waverton Investment Management Ltd decreased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 3.6% during the 3rd quarter, Holdings Channel reports. The firm owned 557,699 shares of the semiconductor company’s stock after selling 20,600 shares during the period. Synopsys comprises about 3.5% of Waverton Investment Management Ltd’s investment portfolio, making the stock its 13th biggest position. Waverton Investment Management Ltd’s holdings in Synopsys were worth $275,372,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in SNPS. Lionshead Wealth Management LLC raised its position in Synopsys by 1.9% during the second quarter. Lionshead Wealth Management LLC now owns 914 shares of the semiconductor company’s stock worth $469,000 after acquiring an additional 17 shares in the last quarter. YANKCOM Partnership increased its stake in shares of Synopsys by 3.3% during the 2nd quarter. YANKCOM Partnership now owns 537 shares of the semiconductor company’s stock worth $275,000 after purchasing an additional 17 shares during the last quarter. Manchester Capital Management LLC raised its holdings in shares of Synopsys by 5.3% in the 2nd quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock valued at $174,000 after purchasing an additional 17 shares during the period. Savvy Advisors Inc. grew its holdings in Synopsys by 3.6% during the second quarter. Savvy Advisors Inc. now owns 551 shares of the semiconductor company’s stock worth $282,000 after purchasing an additional 19 shares during the period. Finally, Advisors Capital Management LLC grew its holdings in Synopsys by 2.3% during the second quarter. Advisors Capital Management LLC now owns 862 shares of the semiconductor company’s stock worth $442,000 after purchasing an additional 19 shares during the period. Institutional investors own 85.47% of the company’s stock.
Synopsys Stock Performance
NASDAQ SNPS opened at $414.00 on Monday. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73. The firm has a 50-day moving average price of $471.21 and a two-hundred day moving average price of $475.21. The company has a market capitalization of $79.31 billion, a P/E ratio of 64.29, a P/E/G ratio of 3.46 and a beta of 1.15. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33.
Insider Activity
In other news, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Janet Lee sold 250 shares of the stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider owned 11,959 shares in the company, valued at $6,338,270. This represents a 2.05% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 4,157 shares of company stock valued at $1,945,036 in the last ninety days. 0.56% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
A number of research firms have recently issued reports on SNPS. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a research report on Thursday, January 22nd. Morgan Stanley reaffirmed an “equal weight” rating and set a $480.00 price target (down from $550.00) on shares of Synopsys in a report on Wednesday. Zacks Research raised shares of Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Citigroup initiated coverage on shares of Synopsys in a research report on Monday, November 24th. They issued a “buy” rating and a $580.00 price objective on the stock. Finally, Rosenblatt Securities decreased their price target on shares of Synopsys from $560.00 to $530.00 and set a “buy” rating on the stock in a research note on Thursday. Eight equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Synopsys has an average rating of “Hold” and an average price target of $531.00.
Read Our Latest Stock Report on Synopsys
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- ATCX is Sitting on One of Brazil’s Largest Critical Minerals Portfolios!
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
